Early Phase
Global Clinical Development
Late Phase
Biometrics
Medical & Regulatory Affairs
Resourcing Solutions
SERVICES Early Phase Facilities and Location First-In-Man & Phototoxicity Trials Volunteer Database Photo Tour of Our Unit Directions to Our Unit Contact Early Phase Study Volunteers Global Clinical Development Late Phase Biometrics Medical & Regulatory Affairs Resourcing Solutions
First-In-Man & Phototoxicity Trials
First-In-Man Trials
We are ideally positioned to perform First-In-Man studies through our 24/7 medical and nursing cover, and our location provides fast access to Ninewells Hospital’s acute medical and surgical admissions areas, intensive/coronary care units and the hospital cardiac arrest team.
All our clinical team members trained in immediate/ advanced life support and our Early Phase team has performed more than 250 First-In-Man studies to date.
Phototoxicity Trials
Chiltern is a recognized industry leader in Phototoxicity trials through our experienced team who have conducted a large number Phototoxicity trials successfully combined with our collaboration with Spectratox Ltd and Professor James Ferguson, a world renowned expert in Photobiology.
For more information on our Phototoxicity expertise and experience, please click on the link opposite.
We are ideally positioned to perform First-In-Man studies through our 24/7 medical and nursing cover, and our location provides fast access to Ninewells Hospital’s acute medical and surgical admissions areas, intensive/coronary care units and the hospital cardiac arrest team.
All our clinical team members trained in immediate/ advanced life support and our Early Phase team has performed more than 250 First-In-Man studies to date.
Phototoxicity Trials
Chiltern is a recognized industry leader in Phototoxicity trials through our experienced team who have conducted a large number Phototoxicity trials successfully combined with our collaboration with Spectratox Ltd and Professor James Ferguson, a world renowned expert in Photobiology.
For more information on our Phototoxicity expertise and experience, please click on the link opposite.
In The Media
Chiltern Announces Its Financial Results For The Year Ended 31 March 2010, 27 July 2010 More
Follow the Project Leader, Chiltern Featured Article in the EPC June 2010 Issue , 30 June 2010 More
Chiltern Launches Collaborative Technologies, 10 June 2010 More
Chiltern Achieves Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency, 7 June 2010 More
Chiltern Announces Early Phase Partnership with Tayside Academic Health Sciences Centre, 2 June 2010 More